DE602004023220D1 - Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a. - Google Patents

Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a.

Info

Publication number
DE602004023220D1
DE602004023220D1 DE602004023220T DE602004023220T DE602004023220D1 DE 602004023220 D1 DE602004023220 D1 DE 602004023220D1 DE 602004023220 T DE602004023220 T DE 602004023220T DE 602004023220 T DE602004023220 T DE 602004023220T DE 602004023220 D1 DE602004023220 D1 DE 602004023220D1
Authority
DE
Germany
Prior art keywords
sodium
naproxes
prominant
aid
hydrogen carbonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004023220T
Other languages
English (en)
Inventor
Peter Gruber
Martin Siegmund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Consumer Care AG
Original Assignee
Bayer Consumer Care AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34529359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004023220(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care AG filed Critical Bayer Consumer Care AG
Publication of DE602004023220D1 publication Critical patent/DE602004023220D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602004023220T 2003-10-30 2004-10-29 Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a. Active DE602004023220D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH18482003 2003-10-30
PCT/CH2004/000655 WO2005041938A1 (en) 2003-10-30 2004-10-29 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate

Publications (1)

Publication Number Publication Date
DE602004023220D1 true DE602004023220D1 (de) 2009-10-29

Family

ID=34529359

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004023220T Active DE602004023220D1 (de) 2003-10-30 2004-10-29 Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a.

Country Status (15)

Country Link
US (1) US20070134317A1 (de)
EP (1) EP1684728B1 (de)
JP (1) JP2007509862A (de)
AR (1) AR046213A1 (de)
AT (1) ATE442840T1 (de)
BR (1) BRPI0415624A (de)
CA (1) CA2543709A1 (de)
CR (1) CR8406A (de)
DE (1) DE602004023220D1 (de)
EC (1) ECSP066587A (de)
ES (1) ES2333332T3 (de)
PA (1) PA8616101A1 (de)
PE (1) PE20050445A1 (de)
UY (1) UY28583A1 (de)
WO (1) WO2005041938A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
JP2008534477A (ja) 2005-03-22 2008-08-28 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 可溶化イブプロフェン
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
US11278506B2 (en) * 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
JP7163014B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 感冒薬
US11779541B2 (en) 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
US5034416A (en) * 1988-01-19 1991-07-23 Smith Walton J Carboxylic acid compositions
PT96229B (pt) * 1989-12-22 1998-06-30 Syntex Pharma Int Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
US5358717A (en) * 1989-12-22 1994-10-25 Syntex (U.S.A.) Inc. Directly-compressible naproxen or naproxen sodium compositions
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
JPH10298072A (ja) * 1997-04-17 1998-11-10 Panacea Biotec Ltd 非ステロイド性抗炎症剤の遷移金属錯体
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
US6383515B2 (en) * 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2002083110A2 (en) * 2001-04-10 2002-10-24 Zagros Pharma, Inc. Animal model for evaluating analgesics
WO2002083105A2 (en) * 2001-04-10 2002-10-24 Zagros Pharma Inc. Composition for enhanced absorption of nsaids

Also Published As

Publication number Publication date
JP2007509862A (ja) 2007-04-19
ES2333332T3 (es) 2010-02-19
CR8406A (es) 2008-04-25
PE20050445A1 (es) 2005-06-18
WO2005041938A1 (en) 2005-05-12
CA2543709A1 (en) 2005-05-12
ATE442840T1 (de) 2009-10-15
US20070134317A1 (en) 2007-06-14
BRPI0415624A (pt) 2006-12-12
AR046213A1 (es) 2005-11-30
ECSP066587A (es) 2006-10-17
EP1684728B1 (de) 2009-09-16
UY28583A1 (es) 2005-05-31
EP1684728A1 (de) 2006-08-02
PA8616101A1 (es) 2005-08-04

Similar Documents

Publication Publication Date Title
IS7826A (is) Lekaskorða fyrir raflausnarker
DE60305603D1 (de) Bankautomat
FI20031133A0 (fi) Sulkimella varustettu liitin
DE60329138D1 (de) Geldautomat
DK2447362T3 (da) Alkaliske cellulasevarianter
NO20025602L (no) Tettet sideforbindelse i borehull
DE50303155D1 (de) Dichtring
DK1478851T3 (da) Offshore-vindmöllepark
DE60311517D1 (de) Multiionophore membranelektrode
NO20040269L (no) Telemetrisystem
DE602004023220D1 (de) Nichtsprudelnde form von natrium-naproxen mit natriumhydrogencarbonat u.a.
DE60313852D1 (de) Elektrokatalytischer farbstoff
DK1335130T3 (da) Darrieus-vindmölle
DE60236765D1 (de) Stromgesteuerter oszillator
DK1518067T3 (da) Bistabil membranventil
DE60315620D1 (de) Gestufte nockengesteuerte matrize
FI20021307A0 (fi) Nimikilpi
IT1337921B1 (it) Bilastra con fondazione
SM200200012A (it) Elettromagnete bistabile
ATE381085T1 (de) Verbesserte abdichtung
ITMO20020017V0 (it) Portaoggetti da spiaggia con chiusura a combinazione.
DOP2002000500A (es) Benzamida, heteroarilamida y amidas inversas
PT9850T (pt) Dobradica melhorada
NO20022617D0 (no) Anode
ITRM20020114A0 (it) Portamonete ingrandente.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition